Publications

  • How the Sick European Banks Can Return to Health

    October 11, 2017 | Forbes.com

    Troubled banks can likely quadruple their market value by taking the right actions.

  • Big Transformation Ahead? You Might Want the Front Line to Lead

    October 09, 2017 | Forbes.com

    An alternative approach to change programs puts the front line at the heart of the transformation.

  • It’s all like a startup. Industrial companies must wake up digital tomorrow - Bain Moscow

    October 06, 2017 | Forbes.ru

    С появлением предиктивной аналитики (то есть предсказательной) изменился подход к сбору идей. Получая данные с различных устройств клиента, производитель лучше понимает, как клиент использует его продукт и что ему нужно

  • Why airline bankruptcies became more frequent? - Bain Moscow

    October 02, 2017 | Digital | Vedomosti

    Партнер Bain & Company Андрей Панов о том, как конкуренция выдавливает перевозчиков в сегмент лоукостеров

  • Capital Gets a Reset

    October 02, 2017 | CFO.com

    CFOs and CEOs will need to shift their strategies to tap the abundance of available capital.

  • Choosing the Right Platform for the Industrial IoT - Bain Moscow

    September 28, 2017 | Bain Brief

    Сейчас решения для внедрения «Интернета вещей» предлагают многие компании— от промышленных гигантов до провайдеров облачных услуг. Как бизнесу сориентироваться в многообразии вариантов?

  • Choosing the Right Platform for the Industrial IoT

    September 28, 2017 | Bain Brief

    Industrial uses promise to be among the largest markets for IoT devices and services. For vendors and OEMs, the question is whether to partner, build or sign on.

  • James Allen: An Introduction to Micro-battles

    September 27, 2017 | Bain video

    James Allen, who leads Bain's Strategy practice, discusses how micro-battles can help companies achieve competitive advantage in a world of faster change.

  • Bain & Co.'s Rafael Natanek on how to make your drug launch a success

    September 27, 2017 | Pharmaceuticals | S&P Global | Media mention

    Following a survey of 100 executives at the top 20 pharmaceutical companies, Rafael Natanek, a partner with Bain & Company, talked to S&P Global Market Intelligence about the critical importance of a successful new drug launch, given that drug companies will derive 25% to 80% of their revenue from

  • When the Front Line Should Lead a Major Transformation - Bain Moscow

    September 26, 2017 | Bain Brief

    Когда возглавлять крупные трансформации в компании лучше фронт-персоналу